Patent · US Active

Method for the detection of sepsis using procalcitonin-3-116

US7723492B2 · kind B2 · utility

14Cited by

3References

9Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Andreas Bergmann · Berlin, DE
Joachim Struck · Berlin, DE
Wolfgang Weglöhner · Berlin, DE

Key dates

Filing date	Sep 29, 2008
Grant date	May 25, 2010
Priority date	—
Expiry date	Sep 29, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/585
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.